Qianjiang Yongan Pharmaceutical Co Ltd

Qianjiang Yongan Pharmaceutical Co., Ltd. announced that the company recently obtained an invention patent certificate from the National Intellectual Property Administration for a method and system for continuously preparing sodium isethionate, with patent number ZL 2023 1 0738883.5. The grant announcement date is August 7, 2026, and the patent is valid for 20 years. Sodium isethionate is an intermediate for pharmaceutical raw materials such as taurine, daily chemical and personal care products, and fine chemical products. The company is a well-known enterprise in the global taurine field. The company stated that this patent will help protect and leverage its independent intellectual property advantages, improve the capacity utilization rate of existing equipment, and achieve product diversification. However, commercialization will take some time and will not have a significant impact on production, operations, or financial performance for the time being.